Mach7 Technologies Ltd. · ASX:M7T
Mach7 Technologies — Investor Presentation (September 2018)
13 slides from Mach7 Technologies's investor presentation, Sep 4, 2018
Slide 1: Mach7 Technologies Investor Presentation
For personal use only MACH7 TECHNOLOGIES INVESTOR PRESENTATION, M7T.ASX SEPTEMBER 2018 MIKE JACKMAN, CEO JENNI PILCHER, CFO Copyright © 2013 Mach7 Technologies
Slide 2: Disclaimer
Disclaimer Summary of information: This presentation contains general and background information about Mach7 Technologies Limited (“M7T”) activities current as at the date of the presentation and should not be considered to be For personal use only comprehensive or to comprise all the information th
Slide 3: Business Highlights – FY18
MACH7 BUSINESS HIGHLIGHTS – FY18 For personal use only Sales growth Expanding the addressable market • Pipeline +50% (last 15 months) to ~$4b • Growing global customer • Engagement of distributors and base across healthcare tiers value-added resellers • Entry into new markets: LATAM & Europe Product
Slide 4: Financial Highlights – FY18
FINANCIAL HIGHLIGHTS – FY18 For personal use only to $5.3m to $13.5m to $7.6m Contracted Sales Orders USA Revenue +24% +12% +16% Annual Recurring Revenue 12% $16,000,000 10,000,000.00 $6,000,000 $14,000,000 $5,000,000 $12,000,000 8,000,000.00 $4,000,000 $10,000,000 6,000,000.00 $8,000,000 $3,000,000
Slide 5: Growth Path
MACH7 GROWTH PATH For personal use only 10110011001 2007 2010 2012 2016 2018 2019 Mach7 Founded First Commercial Wins Listed on ASX (M7T) New Diagnostic, First Pilots Deployed Cloud Deployments Revenue Phase Begins Connected Health and USA & Middle East AI Solutions Growing our addressable Enterpris
Slide 6: Today's Healthcare Problem
Today’s Healthcare Problem For personal use only Inefficient health care delivery due to ~70% of clinical data living outside of the EMR The Mach7 Solution A proven, unique and innovative platform that enables access, interoperability, and liquidity of patient data. Delivering Outcomes Improved pati
Slide 7: Solutions
MACH7 SOLUTIONS For personal use only Enterprise Solutions Diagnostic Solutions Connected Healthcare Artificial Intelligence (current revenue) (new revenue) (new revenue) (new revenue) ARTIFICIAL INTELLIGENCE 10110011001 • VNA • PACS • Image Sharing • Analytics • Enterprise Viewing • Worklist • Care
Slide 8: Platform (Core I.P.)
MACH7 PLATFORM (CORE I.P.) For personal use only Easy Procedure UNIQUE COMPETITIVE ADVANTAGES tracking, Physician & Telehealth / monitoring and Patient Teleradiology Innovative platform with intuitive, point- sharing Portals and-click interface and real-time Rapid monitoring dashboard delivery of pa
Slide 9: Strategy for Success
STRATEGY FOR SUCCESS Innovative healthcare data For personal use only services, intelligent platform & Innovate reconstructed PACS & disrupt the New regions through market indirect channels, VAR, and OEM partners Innovative workflow Solve improvement Enter new common services markets problems Custom
Slide 10: Growing Global Customer Base
GROWING GLOBAL CUSTOMER BASE For personal use only Mach7 Technologies has enterprise customers in the USA , UK, The Netherlands, Saudi Arabia, Qatar, Vietnam, Malaysia, Singapore, India and Indonesia 10
Slide 11: Board and Management
MACH7 BOARD AND MANAGEMENT only MANAGEMENT Mike Jackman Jenni Pilcher Eric Rice Damien Lim Eliot Siegel, MD MANAGING CFO, Company CTO BOARD NON-EXECUTIVE NON-EXECUTIVE DIRECTOR, CEO Secretary CHAIRMAN DIRECTOR For personal use Thought leader in the world of Executive experience in ASX- 20 year
Slide 12: Capital Structure and Major Shareholders
MACH7 TECHNOLOGIES (M7T:AX) For personal use only CAPITAL STRUCTURE MAJOR SHAREHOLDERS Share price (3-Sep-18) $0.21 # shares % (m) Number of shares (m)1 132.2m JM Financial Group 15.7 11.9% Market Capitalisation $27.8m (Melbourne, Australia) Cash (30-June 18) $2.5m Oceania Capital Partners 12.4 9.4%
Slide 13: Full Year 2018 Result
FULL YEAR 2018 RESULT For personal use only FY 2018 FY 2017 % FY 2018 FY 2017 P&L BALANCE SHEET % Change A$m A$m Change A$m A$m Revenue 8.6 $10.3 -16% Cash 2.5 2.7 -7% Operating expenditure (11.6) ($14.6) -21% Net tangible assets 3.0 3.4 -13% Other income/expenses 0.3 0.1 225% Deferred revenue 2.7 2
Mach7 Technologies — Investor Presentation (September 2018) on 6ix